Form 4/A for ORGO Organogenesis Holdings Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-18 · accession 0002064832-26-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-03-03 | 2026-02-18 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $3.84 | -11.9K | 899.7K | -1% | -$45.6K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +48.8K | 911.6K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-18 | F | D | 11,887 | $3.84 | 899,724 | D | — | — | (F1) This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing. |
| 2 | Common | Class A Common Stock | 2026-02-18 | A | A | 48,818 | $0.00 | 911,611 | D | — | — | (F1) This Form 4 is being filed as an amendment to the Form 4 originally filed on February 20, 2026, to correct the number of shares reported as acquired upon the vesting and settlement of a performance share award and the number of shares reported as withheld in satisfaction of tax obligations in connection with such award. No other changes have been made to the original filing. |